Nanoparticles enable large-scale production of advanced cell therapies
Why it matters: This innovation could unlock affordable, large-scale production of next-gen cell therapies, bringing new hope to patients.
- XJTLU researchers have created a streamlined, nanoparticle-based system to mass-produce exosomes, which are tiny therapeutic particles released by cells.
- Exosomes are being investigated as a new class of medical treatment, offering potential for advanced cell therapies.
- The new production method significantly simplifies and scales up the manufacturing process, overcoming a key barrier to clinical application and widespread availability.
Researchers at Xi'an Jiaotong-Liverpool University (XJTLU) have revolutionized the production of therapeutic exosomes, tiny cell-released particles with immense medical potential, by developing a scalable nanoparticle-based system. This breakthrough addresses a major hurdle in bringing advanced cell therapies to widespread clinical use, making these promising treatments more accessible and affordable.
